Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial effects occurring within hours. Glutamate is the prominent excitatory input to the noradrenergic locus coeruleus (LC). The LC is activated by stress in part through this glutamatergic input. Evidence has accrued demonstrating that the LC may be overactive in MDD, while treatment with traditional antidepressants reduces LC activity. Pathological alterations of both glutamatergic and noradrenergic systems have been observed in depressive disorders, raising the prospect that disrupted glutamate-norepinephrine interactions may be a central component to depression and suicide pathobiology. This study examined the gene expression levels of glutamate receptors in post-mortem noradrenergic LC neurons from subjects with MDD (most died by suicide) and matched psychiatrically normal controls. Gene expression levels of glutamate receptors or receptor subunits were measured in LC neurons collected by laser capture microdissection. MDD subjects exhibited significantly higher expression levels of the NMDA receptor subunit genes, GRIN2B and GRIN2C, and the metabotropic receptor genes, GRM4 and GRM5, in LC neurons. Gene expression levels of these receptors in pyramidal neurons from prefrontal cortex (BA10) did not reveal abnormalities in MDD. These findings implicate disrupted glutamatergic-noradrenergic interactions at the level of the stress-sensitive LC in MDD and suicide, and provide a theoretical mechanism by which glutamate antagonists may exert rapid antidepressant effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572
The Universal Protein Resource (UniProt)
Bairoch, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki070 · Cited by 3,774
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Function and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127 · cited 2×
“Elevated glutamate receptor gene expression in MDD 1575 D ow nloaded from https://academ ic.oup.com /ijnp/article/17/10/1569/2356907 by guest on 04 M ay 2021 ionotropic glutamate receptors (Lonze and Ginty, 2002; Papadia et al., 2005).”
Price, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600 · cited 1×
“In fact, a single brief infusion of ketamine reduces suicide ideation within an hour, and the effect persists up to 24 h (Price et al., 2009; Diazgranados et al., 2010).”
DiazGranados, N., Ibrahim, L. A., Brutsche, N. E., Ameli, R., Henter, I. D., Luckenbaugh, D. A., Machado-Vieira, R., & Zarate, C. A. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05327blu · Cited by 564
Harrison, P. J., Heath, P. R., Eastwood, S. L., Burnet, P. W. J., McDonald, B., & Pearson, R. C. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12102-a · Cited by 342 · cited 2×
“1570 M.J. Chandley et al. D ow nloaded from https://academ ic.oup.com /ijnp/article/17/10/1569/2356907 by guest on 04 M ay 2021 pH (Harrison et al., 1995), RNA integrity number (RIN), post-mortem interval (PMI), and storage time in freezer were matched as closely as possible (Table 2).”
Deep brain stimulation of the lateral habenula in treatment resistant major depression
Sartorius, A., & Henn, F. A. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.03.021 · Cited by 251
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity
Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., & Stockmeier, C. A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.003 · Cited by 218 · cited 1×
“The present study contributes to growing evidence of altered glutamatergic input to the noradrenergic LC in MDD (Karolewicz et al., 2005; Miguel-Hidalgo et al., 2010; Chandley et al., 2013).”
Self-citationHasler, G., Fromm, S., Carlson, P. J., Luckenbaugh, D. A., Waldeck, T., Geraci, M., Roiser, J. P., Neumeister, A., Meyers, N., Charney, D. S., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.521 · Cited by 209 · cited 1×
“Norepinephrine (NE)-depletion in humans with a history of depression can re-induce depression (Berman et al., 1999; Hasler et al., 2008).”
Research works printed but not linked: 33
- 10.1093/nar/gkn141 · DOI · Paper page
- 10.1006/geno.2002.6748 · DOI · Paper page
- 10.1001/archpsyc.61.7.705 · DOI · Paper page
- 2008, Drug News Perspect, 21, 581
- 10.1001/archpsyc.1986.01800060071009 · DOI · Paper page
- 10.1521/suli.2009.39.1.38 · DOI
- 10.1046/j.1365-2826.2002.00821.x · DOI · Paper page
- 10.1146/annurev.pharmtox.37.1.205 · DOI · Paper page
- 10.1523/JNEUROSCI.5019-04.2005 · DOI · Paper page
- 10.1503/jpn.120110 · DOI · Paper page
- 10.1007/s00213-005-2142-5 · DOI
- 1979, Acta Psychiatr Scand, 277, 1
- 10.1002/jnr.22078 · DOI
- 10.1001/archpsyc.56.5.395 · DOI · Paper page
- 1989, Naunyn Schmiedebergs Arch Pharmacol, 339, 312
- 10.1126/science.3775363 · DOI · Paper page
- 10.1016/j.brainres.2007.08.007 · DOI
- 10.1007/BF02245873 · doi:10.1007/bf02245873
- 10.4088/JCP.v69n0308 · DOI · Paper page
- 10.1073/pnas.88.19.8382 · DOI · Paper page
- 10.1016/j.mehy.2011.06.021 · DOI
- 10.1001/jama.2011.1080 · DOI · Paper page
- 1997, J Neurosci, 17, 8842, 10.1523/JNEUROSCI.17-22-08842.1997 · DOI · Paper page
- 10.1111/j.1600-0447.1996.tb09869.x · DOI · Paper page
- 10.1038/sj.npp.1300781 · DOI
- 10.1016/S0006-8993(97)00703-8 · DOI
- 10.1016/j.neuropharm.2012.04.007 · DOI
- 10.1002/cne.901870103 · DOI · Paper page
- 10.1016/0006-8993(91)90939-S · DOI
- 10.1111/j.1476-5381.2008.00004.x · DOI
- 10.1017/S1461145708009474 · DOI · Paper page
- 10.1016/S0006-3223(00)00936-7 · DOI
- 10.1007/BF00964456 · DOI
Cited by
Turecki, G., Brent, D. A., Gunnell, D., O’Connor, R. C., Oquendo, M. A., Pirkis, J., & Stanley, B. H. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0121-0 · Cited by 1,074
Self-citationHoward, D. M., Adams, M. J., Shirali, M., Clarke, T.-K., Marioni, R. E., Davies, G., Coleman, J. R. I., Alloza, C., Shen, X., Barbu, M. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03819-3 · Cited by 612
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Targeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Li, Z., Ruan, M., Chen, J., & Fang, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00638-3 · Cited by 326
Metadata
- Authors
- Chandley, M. J., Szebeni, A., Szebeni, K., Crawford, J. D., Stockmeier, C. A., Turecki, G., Kostrzewa, R. M., & Ordway, G. A.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-13
- Volume
- 17
- Issue
- 10
- Pages
- 1569-1578
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2164591389
- Cited by
- 111
- References
- 12
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression. https://app.cochat.ai/papers/10.1017/s1461145714000662
- The paper
- Chandley, M. J., Szebeni, A., Szebeni, K., Crawford, J. D., Stockmeier, C. A., Turecki, G., Kostrzewa, R. M., & Ordway, G. A. (2014). Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145714000662
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.